A Five‑long Non‑coding RNA Signature With the Ability to Predict Overall Survival of Patients With Lung Adenocarcinoma

Experimental and Therapeutic Medicine - Greece
doi 10.3892/etm.2019.8138
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

A Four-Long Non-Coding RNA Signature in Predicting Breast Cancer Survival

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Peer Review #2 of "A Six-microRNA Signature Can Better Predict Overall Survival of Patients With Esophagus Adenocarcinoma (V0.2)"

2019English

Peer Review #1 of "A Six-microRNA Signature Can Better Predict Overall Survival of Patients With Esophagus Adenocarcinoma (V0.2)"

2019English

A Five-Gene Signature Predicts Overall Survival of Patients With Papillary Renal Cell Carcinoma

PLoS ONE
Multidisciplinary
2019English

Development and Validation of Novel Signature to Predict Overall Survival in "Driver-Gene-Negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study

Clinical Cancer Research
Cancer ResearchOncology
2018English

Long Non‑coding RNA DANCR Promotes HMGA2‑mediated Invasion in Lung Adenocarcinoma Cells

Oncology Reports
MedicineCancer ResearchOncology
2018English

A Three-Long Non-Coding RNA Signature Derived From the Cancer Genome Atlas Database Predicts the Survival of Patients With Head and Neck Squamous Cell Carcinoma

International Journal of Oral and Maxillofacial Surgery
OtorhinolaryngologyOral SurgerySurgery
2017English

A Seven-Gene Signature Predicts Overall Survival of Patients With Colorectal Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy